Renal biopsy is the gold standard in the diagnosis of glomerular diseases, helping to guide and individualize treatment, especially treatment with immunosuppressive drugs. Objective: To evaluate the rate and characteristics of changes in indications for immunosuppressive drug treatment after renal biopsy results in patients with glomerular diseases. Methods: Observational cohort. Location: Center for Nephrology, Urology and Dialysis, Bach Mai Hospital. Time: From January 2024 to February 2026. Results: A total of 554 patients were studied. The rate of patients whose immunosuppressive drug treatment was changed after renal biopsy results was 46%, and there were differences among groups of glomerular diseases. The rate of change was 100% in rapidly progressive glomerulonephritis, 74.5% in lupus nephritis, 44.7% in IgA nephropathy, 37.3% in nephrotic syndrome, and 35.1% in other glomerular diseases. Among the patients whose treatment was changed, 31.8% were started on immunosuppressive drugs, 56.9% had their immunosuppressive drug treatment intensified, 3.1% had the treatment intensity reduced, 5.1% were switched to another regimen, and 3.1% discontinued immunosuppressive drugs. Conclusion: The rate of patients whose immunosuppressive drug treatment was changed after renal biopsy results was 46%, of whom the majority were started on or had their immunosuppressive drug treatment intensified.
ASSESSMENT OF THE RATE AND CHARACTERISTICS OF TREATMENT CHANGES FOLLOWING RENAL BIOPSY RESULTS IN PATIENTS WITH GLOMERULAR DISEASES
266
Views
0
Downloads
Keywords
Treatment modification, renal biopsy, glomerular disease
Abstract
References
[1]
(1) Moroni, G.; Calatroni, M.; Donato, B.; Ponticelli, C. Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis. J. Clin. Med. 2023, 12 (5), 1834. https://doi.org/10.3390/jcm12051834.
Google Scholar
[2]
(2) Glassock, R. J. The Pathogenesis of Idiopathic Membranous Nephropathy: A 50-Year Odyssey. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 2010, 56 (1), 157–167. https://doi.org/10.1053/j.ajkd.2010.01.008.
Google Scholar
[3]
(3) Heptinstall’s Pathology of the Kidney, Seventh edition.; Jennette, J. C., Olson, J. L., Silva, F. G., D’Agati, V. D., Eds.; Lippincott Williams & Wilkins/Wolters Kluwer: Philadelphia, 2015.
Google Scholar
[4]
(4) poyanmehr. Kidney Biopsy From Needle to Report: The Basics. GlomCon (pubs). https://pubs.glomcon.org/kidney-biopsy-from-needle-to-report-the-basics/ (accessed 2025-07-11).
Google Scholar
[5]
(5) Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021, 100 (4S), S1–S276. https://doi.org/10.1016/j.kint.2021.05.021.
Google Scholar
[6]
(6) Hoàng, T. T. H. Mô Tả Đặc Điểm Lâm Sàng, Cận Lâm Sàng Có Đối Chiếu Với Mô Bệnh Học Của Bệnh Nhân Cầu Thận Tại Bệnh Viện Bạch Mai. Master’s thesis, Đại học Y Hà Nội, Việt Nam, 2020.
Google Scholar
[7]
(7) Hoàng, A. T. Nghiên Cứu Đặc Điểm Lâm Sàng, Cận Lâm Sàng và Mô Bệnh Học Của Bệnh Nhân Hội Chứng Thận Hư Nguyên Phát Điều Trị Tại Khoa Thận Tiết Niệu Bệnh Viện Bạch Mai. Master’s thesis, Đại học Y Hà Nội, 2015.
Google Scholar
[8]
(8) Nguyễn, T. M. T. Nghiên Cứu Đặc Điểm Mô Bệnh Học Miễn Dịch Huỳnh Quang và Mối Liên Quan Với Lâm Sàng, Sinh Hoá Máu Của Một Số Bệnh Cầu Thận Nguyên Phát ở Người Lớn. Master’s thesis, Đại học Y Hà Nội, Việt Nam, 2019.
Google Scholar
[9]
(9) Zhang, T.; Yang, X.; Zhang, M.; Zhou, W.; Jin, Y.; Zhou, H.; Zhou, Y.; Wang, Q.; Mou, S. Effects of Receiving Renal Biopsy on the Prognosis of Chronic Kidney Disease Patients with Impaired Renal Function. BMC Nephrol. 2023, 24 (1), 56. https://doi.org/10.1186/s12882-023-03097-2.
Google Scholar
[10]
(10) Schnuelle, P. Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety. J. Clin. Med. 2023, 12 (19), 6424. https://doi.org/10.3390/jcm12196424.
Google Scholar
[11]
(11) Hsieh, Y. P.; Wen, Y. K.; Chen, M. L. The Value of Early Renal Biopsy in Systemic Lupus Erythematosus Patients Presenting with Renal Involvement. Clin. Nephrol. 2012, 77 (1), 18–24. https://doi.org/10.5414/cn107094.
Google Scholar
[12]
(12) Turner, M. W.; Hutchinson, T. A.; Barré, P. E.; Prichard, S.; Jothy, S. A Prospective Study on the Impact of the Renal Biopsy in Clinical Management. Clin. Nephrol. 1986, 26 (5), 217–221.
Google Scholar